The usual cause for the fund is to invest in rounds with 10 partakers. The meaningful sponsors for the fund in investment in the same round are Woodward Angels, RBI Opportunities Fund, Michigan Angel Fund.
Among the various public portfolio startups of the fund, we may underline Ocuphire Pharma Among the most successful fund investment fields, there are Pharmaceutical, Biopharma. Besides, a startup needs to be aged 1 and less years to get the investment from the fund.
The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2019. The usual things for fund are deals in the range of 5 - 10 millions dollars.
| Fund Name | Location |
| 7home | Hanoi, Vietnam |
| Bedrock Ventures | Delhi, Delhi, India |
| British Land | England, London, United Kingdom |
| Clal Industries and Investments (CII) | Israel, Tel Aviv, Tel Aviv District |
| Dentsu Group | Chiyoda, Japan |
| EMD, LLC | - |
| Forgame | China, Guangdong, Guangzhou |
| Hivos-Triodos Fund | - |
| Inteliquent | Chicago, Illinois, United States |
| Kayne Partners | California, Los Angeles, United States |
| Oracle Capital Partners | Detroit, Michigan, United States |
| Pharus Capital Management | California, San Francisco, United States |
| Rockwood Capital, LLC | New York, United States, White Plains |
| Souhiti Infraprojects | Andhra Pradesh, India, Telangana |
| Structure Fund | California, Los Angeles, United States |
| SunBridge Global Ventures | Japan, Osaka, Osaka Prefecture |
| Topspin Medical | HaMerkaz, Israel, Lod |
| UnitedBrandWorks | Florida, Palm Beach, United States |
| Vision Brazil Investments | Brazil, Espirito Santo, Pernambuco |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Ocuphire Pharma | $5M | 22 Jul 2019 | Michigan, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Ocuphire Pharma | $5M | 22 Jul 2019 | Michigan, United States |
